SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

531739

INE509C01026

8.9778497

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

15.1

249.51

EPS(TTM)

Face Value()

Div & Yield %

0.68

Back

Piramal Pharma reports consolidated net loss of Rs 69.39 crore in the June 2026 quarter

Jul 30,2026

Net Loss of Piramal Pharma reported to Rs 69.39 crore in the quarter ended June 2026 as against net loss of Rs 81.70 crore during the previous quarter ended June 2025. Sales rose 17.39% to Rs 2269.92 crore in the quarter ended June 2026 as against Rs 1933.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2269.92	1933.71	17
OPM %	8.60	5.52	-
PBDT	216.09	97.52	122
PBT	-7.46	-99.76	93
NP	-69.39	-81.70	15

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)